U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07353957) titled 'Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer' on Jan. 16.
Brief Summary: The study will test the efficacy and safety of petosemtamab in combination with Pembrolizumab in first line patients with squamous non-small cell lung cancer and non-squamous non-small cell lung cancer.
Study Start Date: Dec. 31, 2025
Study Type: INTERVENTIONAL
Condition:
Lung Cancer - Non Small Cell Squamous
Lung Cancer - Non Small Cell Non-Squamous
Intervention:
COMBINATION_PRODUCT: Petosemtamab + Pembrolizumab
Petosemtamab + Pembrolizumab
Recruitment Status: RECRUITING
Sponsor: Merus N.V.
Published by HT Di...